SCOPE HEALTH recalls Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Ma
Recalled May 6, 2026 · FDA recall D-0499-2026 · SCOPE HEALTH
Hazard
Lack of Assurance of Sterility · FDA Class II
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
Manufacturer(s)
SCOPE HEALTH
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →